TRENDS AND SURVIVAL FOR AIDS PATIENTS PRESENTING WITH INDICATIVE NEUROLOGIC DISEASES

被引:10
作者
CASABONA, J
SANCHEZ, E
GRAUS, F
ABOS, J
SEGURA, A
机构
[1] HOSP CLIN BARCELONA,GENERALITAT CATALUNYA,AIDS PREVENT & CONTROL PROGRAM,BARCELONA 36,SPAIN
[2] HOSP CLIN BARCELONA,DEPT NEUROL,BARCELONA 36,SPAIN
来源
ACTA NEUROLOGICA SCANDINAVICA | 1991年 / 84卷 / 01期
关键词
AIDS; TOXOPLASMOSIS; SURVIVAL; INDICATIVE NEUROLOGIC DISEASE;
D O I
10.1111/j.1600-0404.1991.tb04902.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Nervous system involvement in patients with AIDS is frequent either due to direct infection by the HIV-1 or to opportunistic infections or neoplasms. In the present study we evaluate the epidemiologic characteristics of patients in whom the first AIDS manifestation was an indicative neurologic disease (IND) and the influence of such a presenting form in the patients' survival. Out of 1250 reported cases, 252 (20.2%) presented with one of the INDs, according with the CDC AIDS definition criteria. Neither sex nor age differences were found between patients presenting with and without an IND. IVDUs were more likely to present with an IND than homosexual/bisexual men (p = 0.024). Cerebral toxoplasmosis (CT) was the only IND with a significant proportional increase over time. Although some of the IND have a specific treatment, as a whole patients presenting with an IND lived shorter than those presenting with any of the other indicative disorders (p < 0.0001). The incidence of IND is greater than elsewhere, mainly because of CT. The increment of CT may be in part due to the introduction of the new AIDS definition criteria.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 25 条
[1]  
ABOS J, 1989, NEUROLOGIA, V3, P272
[2]  
CASABONA J, 1989, MED CLIN-BARCELONA, V92, P441
[3]  
CASABONA J, 1990, J ACQ IMMUN DEF SYND, V3, P272
[4]  
CROWLEY J, 1984, ANNU REV PUBL HEALTH, V5, P385
[5]   AIDS AND THE NERVOUS-SYSTEM [J].
DALAKAS, M ;
WICHMAN, A ;
SEVER, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (16) :2396-2399
[6]   NEUROLOGICAL COMPLICATIONS OF INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 - A REVIEW OF LITERATURE AND 241 CASES [J].
DEGANS, J ;
PORTEGIES, P .
CLINICAL NEUROLOGY AND NEUROSURGERY, 1989, 91 (03) :199-219
[7]   NEUROLOGIC MANIFESTATIONS OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS - CLINICAL-FEATURES AND PATHOGENESIS [J].
GABUZDA, DH ;
HIRSCH, MS .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (03) :383-391
[8]   THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) DEMENTIA COMPLEX [J].
HO, DD ;
BREDESEN, DE ;
VINTERS, HV ;
DAAR, ES .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (05) :400-410
[9]  
KOPPEL BS, 1985, ACTA NEUROL SCAND, V71, P337
[10]   TREATMENT OF CENTRAL NERVOUS-SYSTEM TOXOPLASMOSIS WITH PYRIMETHAMINE SULFADIAZINE COMBINATION IN 35 PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME - EFFICACY OF LONG-TERM CONTINUOUS THERAPY [J].
LEPORT, C ;
RAFFI, F ;
MATHERON, S ;
KATLAMA, C ;
REGNIER, B ;
SAIMOT, AG ;
MARCHE, C ;
VEDRENNE, C ;
VILDE, JL .
AMERICAN JOURNAL OF MEDICINE, 1988, 84 (01) :94-100